BiotechnologyJanuary 22, 20267 min read
From Bedside to Bench: Why Medicine Needs Biotechnology
By Dr. Robert Sakulanda

When I told colleagues I was leaving a clinical schedule to earn a Master's degree in biotechnology, the reactions fell into two camps. Some thought it was a detour. Others — usually the ones who had lived through the pandemic wards with me — understood immediately.
Two languages, one patient
Clinical medicine and laboratory science describe the same human being in different languages. On the ward, we speak in symptoms, trajectories, and conversations. In the laboratory, the same story is told in receptors, transcripts, and trial endpoints. Both are true. Neither is complete.
The pandemic made the cost of that divide visible to everyone. mRNA vaccines went from sequence to syringe in under a year — an astonishing scientific achievement — and yet the hardest work was still human: earning trust, correcting misinformation, and delivering doses into arms in communities that had every historical reason to be skeptical.
The hardest part of a scientific breakthrough is rarely the science. It is the translation.
What biotechnology taught me about medicine
Studying vaccines, gene editing, and emerging therapies changed how I read the news, but more importantly it changed how I talk to patients. When a family asks whether a new treatment is "natural," or whether gene therapy means "changing who someone is," I understand the science well enough to answer honestly — and the wards well enough to answer gently.
A few things I wish every clinician could learn in a laboratory:
- How vaccines actually work at the molecular level, and why the immune system's memory is the quiet miracle of modern medicine.
- What CRISPR can and cannot do — and why "editing a gene" is a phrase that deserves far more care than a headline gives it.
- How a therapy travels from bench discovery through trials to a prescription pad, and why that journey takes so long.
The bridge is the point
I did not leave medicine for science; I went looking for the bridge between them. The future of care is being written in both places — at bedsides and at benches. Somebody has to be fluent enough in each to carry the story across.
That, as much as anything, is why I write.
Published January 22, 2026
Keep reading
All articlesBiotechnology
Editing the Code of Life: A Physician's View of Gene Therapy
Gene editing sounds like science fiction until you meet the patients it could save. A grounded look at what CRISPR-era medicine can honestly promise — and what it cannot.
Entrepreneurship
Why a Physician Bought a Football Club
In 2017 I bought Nkwiza FC, a small club in Zambia's Copperbelt, and rebuilt it as Mufulira United. People asked why a doctor in America wanted a football team. The answer has everything to do with health.

